(Q41670611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

V Jackson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

W Ferguson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

T B Kelleher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Lawless

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Eogan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

U Nusgen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Coughlan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

J Connell

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

9 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

619-623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25381607%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-014-2270-0

22 February 2020

exact match

0 references

cites work

Global epidemiology of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Hepatitis B: Epidemiology and prevention in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Lamivudine treatment for acute severe hepatitis B: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Lamivudine treatment for severe acute HBV hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Hepatitis B viral genotypes and lamivudine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Determinants for sustained HBeAg response to lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2270-0

Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?

21 January 2018

1 reference

12 December 2020

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine

1 reference

12 December 2020

Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B.

1 reference

12 December 2020

Long-term therapy of chronic hepatitis B with lamivudine.

1 reference

12 December 2020

Letters to the Editor

1 reference

12 December 2020

Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis

1 reference

12 December 2020

Exacerbation of chronic hepatitis B infection after delivery

1 reference

12 December 2020

Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B

1 reference

12 December 2020

Perinatal transmission of hepatitis B virus: an Australian experience

1 reference

12 December 2020

Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers

1 reference

12 December 2020